2-230910019-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005683.4(GPR55):c.944C>T(p.Thr315Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005683.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR55 | NM_005683.4 | c.944C>T | p.Thr315Met | missense_variant | 2/2 | ENST00000650999.1 | NP_005674.2 | |
GPR55 | XM_005246952.5 | c.944C>T | p.Thr315Met | missense_variant | 2/2 | XP_005247009.1 | ||
GPR55 | XM_011512175.4 | c.944C>T | p.Thr315Met | missense_variant | 2/2 | XP_011510477.1 | ||
GPR55 | XM_011512176.3 | c.944C>T | p.Thr315Met | missense_variant | 2/2 | XP_011510478.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR55 | ENST00000650999.1 | c.944C>T | p.Thr315Met | missense_variant | 2/2 | NM_005683.4 | ENSP00000498258.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250766Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135590
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461000Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726750
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74362
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at